
X-Therma Inc Profile last edited on: 1/3/2022
CAGE: 7AR15
UEI: MKP9GFAJNEY9
Business Identifier: Convergent biopreservation platform to advance regenerative medicine Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 13
County: Alameda
Congr. District: 13
County: Alameda
Public Profile
With CA- based research centers in Richmond and Berkeley, and a recent expansion into Austria (Europe), X-Therma Inc is structured around developing technology for regenerative medicine and organ preservation. The firm has developed cold chain technology via a convergent biopreservation platform, to advance Regenerative Medicine and make available safe and on-demand organs, engineered tissues, cell & gene therapies, vaccines, and beyond to patients in need. The firm's flagship product XT-Thrive®, a DMSO-, Serum-, Protein-free and chemically defined cryopreservation solution directly plugs into the current CMC workflow, resolves bottlenecks in the cell manufacturing process, and enables off-the-shelf living medicines.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2023 | 1 | NIH | $971,228 | |
Project Title: Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants | ||||
2021 | 2 | NSF | $1,468,317 | |
Project Title: Developing Nanopores to Facilitate Delivery of Intracellular Cryoprotectants for Biopreservation at Low Temperature | ||||
2018 | 2 | Army | $1,149,734 | |
Project Title: A DMSO-Free Biomimetic Cryoprotective Matrix System for Bone Marrow Banking | ||||
2017 | 2 | DHA | $1,153,602 | |
Project Title: Novel Supercooling Protocol for Long-term Storage and Banking of Penile Tissue | ||||
2016 | 2 | DHA | $1,149,929 | |
Project Title: Optimization of Cryoprotectants, Cryotherapeutics, and Protocols for Cryopreservation of Large Tissue Systems |
Key People / Management
Xiaoxi Wei -- CEO and Founder
Mark A Kline -- Chief Technology Officer, Co-Founder
Jie Tian -- Director of Marketing
Mark A Kline -- Chief Technology Officer, Co-Founder
Jie Tian -- Director of Marketing
Company News
There are no news available.